Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Single efficacy trial for transdermal buspirone required by FDA

June 25, 1997

IND approved for multiple sclerosis drug from TCAR program

June 25, 1997

Preclinical and preliminary clinical results reported for alniditan

June 25, 1997

Zolmitriptan: a new antimigraine agent with peripheral and central sites of action

June 25, 1997

5-HT1B receptor antagonists claimed by SKB

June 25, 1997

Centrally active muscarinic agents from American Home Products

June 25, 1997

NOS inhibitors disclosed by Astra for stroke and other disorders

June 25, 1997

Boehringer Ingelheim discloses tachykinin antagonists

June 25, 1997

Safety and pharmacokinetics of JTP-4819 in healthy volunteers

June 24, 1997

SmithKline Beecham introduces ReQuip in Germany

June 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...